Better Plant Sciences Inc.

We leverage modern science to make natural products that work. Better Plant Sciences Inc. offers a collection of high-efficacy, plant-based products for optimum health and wellness. We are a vertically-integrated company with a team whose complementary experience enables acquisition, development, manufacturing, and direct-to-consumer distribution of our products. We're on a mission to make better choices, Create better products and experience, Be a better company.

Recent News

Better Enters Agreement to Acquire JUSU Plant-Based Assets for $2.25 Million

Vancouver, British Columbia--(Newsfile Corp. - August 18, 2020) - Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: BOSQF) (FSE: YG3) ("Better") announces that it has entered into an agreement to acquire JUSU branded plant-based assets from JUSU Bar Inc., JUSU Life Inc. and JUSU Cbd Inc. The assets include all inventory, packaging, raw ingredients, and intellectual property related to 300 plant-based products for the home, body and baby, as well as the e-commerce sites where the products are...

2020-08-18 6:00 AM EDT

Yield Growth Announces Name Change and Provides Corporate Update

Vancouver, British Columbia--(Newsfile Corp. - August 13, 2020) - The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) (the "Company") announces that it will be changing its corporate name to Better Plant Sciences Inc. to reflect its strategic focus on the fast-growing market for plant-based consumer products. The Company's new stock symbol on the CSE will be "PLNT", and the name change will be effective on Tuesday, August 18, 2020.

2020-08-13 6:00 AM EDT

NeonMind Submits Application for Psilocybin Research to Health Canada

Vancouver, British Columbia--(Newsfile Corp. - August 6, 2020) - The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) majority owned subsidiary NeonMind Biosciences Inc. ("NeonMind") announces submission of an application to Health Canada for an exemption to use a controlled substance for scientific purposes, pursuant to Section 56(1) of the Controlled Drugs and Substances Act, S.C. 1996, c. 19 (a "Section 56 Exemption") for NeonMind's planned preclinical trial using psilocybin.

2020-08-06 6:00 AM EDT

Yield Growth Closes $1.4 Million Financing

Vancouver, British Columbia--(Newsfile Corp. - July 30, 2020) - The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) (the "Company") announces that it has closed financings totalling $1.4 million this week. The financing consisted of $700,000 in units offered through a shelf prospectus supplement at a price of $0.10 per unit (each unit consisting of one share and one warrant to purchase a common share for $0.11 over a 2 year period), as well as an additional $700,000 through...

2020-07-30 6:00 AM EDT

Yield Growth Launches Shopify Online Store to Bolster Direct to Consumer Sales

Vancouver, British Columbia--(Newsfile Corp. - July 22, 2020) - The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) ("Yield Growth" or the "Company") is pleased to announce the launch of its new e-commerce website for subsidiary brand, Urban Juve, powered by leading ecommerce platform, Shopify.Yield Growth Launches Shopify Online Store to Bolster

2020-07-22 3:00 AM EDT

Yield Growth's Plant-Based Products List for Sale on Amazon

Vancouver, British Columbia--(Newsfile Corp. - July 16, 2020) - The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) ("Yield Growth") is pleased to announce that eight of its Urban Juve products are now listed for sale on Amazon.ca and are available to both regular and Prime members.Figure 1: Yield Growth’s Plant-Based Products L

2020-07-16 6:00 AM EDT

Yield Growth's Plant-Based Products and Hand Sanitizers to be Sold in Pharmasave

Vancouver, British Columbia--(Newsfile Corp. - July 14, 2020) - The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) is pleased to announce that its Urban Juve products are now available in select Pharmasave stores in multiple provinces across Canada.Graphic: Yield Growth’s Plant-Based Products and Hand Sanitizers to be Sold in PharmasaveTo view an enhanced version of this graphic, please visit:

2020-07-14 6:00 AM EDT

Yield Growth Announces Manufacturing of Plant-Based Deodorant

Vancouver, British Columbia--(Newsfile Corp. - July 9, 2020) - The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) is pleased to announce that it has completed an initial 5,000 product run of a new deodorant SKU for plant-based brand, Antler.Yield Growth Announces Manufacturing of Plant-Based DeodorantTo view an enhanced version of this graphic, please visit:https://orders.newsf

2020-07-09 6:00 AM EDT

Yield Growth Receives Health Canada Notification Numbers for 23 Plant-Based Products

Vancouver, British Columbia--(Newsfile Corp. - June 25, 2020) - The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) ("Yield Growth") is pleased to announce it has received 23 new cosmetic notification ("CN") numbers from Health Canada for its proprietary plant-based products to be launched under various brand collections. Image 1: Yield Growth Receives Health Canada Notification Numbers for 23 Plant-Based ProductsTo view an enhanced version of Image 1, plea

2020-06-25 6:00 AM EDT

Yield Growth Announces Financing

Vancouver, British Columbia--(Newsfile Corp. - June 24, 2020) - The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) (the "Company") announces a proposed non-brokered private placement of special warrants at a price of $0.10 per special warrant (the "Special Warrants") for gross proceeds of up to $1,000,000, with an over allotment option (the "Offering").Each Special Warrant is convertible without payment of additional consideration by the subscriber into a unit (a "Unit") consisting...

2020-06-24 7:22 PM EDT

Yield Growth Announces New Canadian Distributor for its Urban Juve Products

Vancouver, British Columbia--(Newsfile Corp. - June 23, 2020) - The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) is pleased to announce it has signed a Distribution & Sales Agreement with Vancouver-based Ecotrend Ecologics ("Ecotrend") for exclusive distribution of its Urban Juve product line in wellness channels. Yield Growth Announces New Canadian Distributor for it

2020-06-23 6:00 AM EDT

NeonMind Files Patent Application for Therapeutic Use of DMT

Vancouver, British Columbia--(Newsfile Corp. - June 18, 2020) - The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) announces that its majority owned subsidiary NeonMind has filed an additional provisional patent application related to using psychedelics as medicine. The most recent patent application, filed on June 17, 2020 covers the administration of DMT to treat compulsive eating disorder and other illnesses.NeonMind Files Patent Application for Therapeutic

2020-06-18 6:00 AM EDT

Yield Growth Provides Product Manufacturing Update

Vancouver, British Columbia--(Newsfile Corp. - June 16, 2020) - The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) is pleased to share an update on the production and intended rollout and sales of select products in its Urban Juve line and its white label manufacturing operations. Image 1: Yield Growth Provides Product Manufacturing UpdateTo view an enhanced version of Image 1, please visit:

2020-06-16 6:00 AM EDT

NeonMind Expands Development of Psychedelic Patent Portfolio

Vancouver, British Columbia--(Newsfile Corp. - June 9, 2020) - The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) announces that it's majority owned subsidiary NeonMind has filed an additional provisional patent application related to using psychedelics as medicine. The patent application covers the administration of a compound selected from the group consisting of lysergic acid diethylamide ("LSD") and d-lysergic acid amide ("LSA") (and compounds with similar molecular structure)in...

2020-06-09 6:00 AM EDT

NeonMind Files for U.S. Provisional Patent to Use Psychedelic-Assisted Psychotherapy for Weight Loss

Vancouver, British Columbia--(Newsfile Corp. - June 4, 2020) - The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) announces that its majority owned subsidiary NeonMind, on June 3, 2020 filed a U.S. provisional patent application in the United States for the invention relating to therapeutic administration of psilocybin or psilocin (or analogs thereof) ("Psilocybin") combined with supportive therapeutic treatment for a patient to provide weight loss benefits and treatment for related...

2020-06-04 2:00 AM EDT

Yield Growth Manufactures Hand Sanitizers & Prepares for Amazon Prime Sales

Vancouver, British Columbia--(Newsfile Corp. - May 28, 2020) - The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) announces that it has successfully completed its first manufacturing run of Urban Juve hand sanitizer spray and is now fulfilling retail and consumer pre-orders. This includes individual consumers, Canadian online retailers and brick and mortar retail stores such as Pharmasave. Yield Growth Manufactures Hand Sanitizers & Prepares for Amazon Prime

2020-05-28 6:00 AM EDT

NeonMind Taking Steps to Prove Psilocybin Effective for Weight Loss

Vancouver, British Columbia--(Newsfile Corp. - May 21, 2020) - The Yield Growth Corp. (CSE :BOSS) (OTCQB: BOSQF) (FSE: YG3) majority owned subsidiary NeonMind Biosciences Inc. ("NeonMind") has taken further steps towards commencing its clinical studies to confirm that psilocybin (a compound in psychedelic mushrooms) is an effective treatment for food cravings and weight loss. NeonMind has now identified a source of psilocybin in Canada and has identified a laboratory at a University in Canada...

2020-05-21 6:00 AM EDT

NeonMind Completes Design of Preclinical Psilocybin Psychedelic Mushroom Study

Vancouver, British Columbia--(Newsfile Corp. - May 14, 2020) - The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) announces its majority owned subsidiary NeonMind has completed the design of a preclinical study to confirm that psilocybin (found in psychedelic mushrooms) is an effective treatment for weight loss and food craving. NeonMind engaged Translational Life Sciences Inc. ("TLS"), a contract research organization, to design the study. The TLS team is composed of physicians and...

2020-05-14 2:00 AM EDT

NeonMind and Translational Life Sciences to Design Psilocybin Mushroom Clinical Trials

Vancouver, British Columbia--(Newsfile Corp. - May 7, 2020) - The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) announces its majority owned subsidiary NeonMind has entered into an agreement entitled "CLINICAL TRIALS START-UP STUDY AGREEMENT" with Translational Life Sciences Inc. ("TLS") to initiate clinical trials to test certain potential therapeutic effects of psilocybin and other compounds in psychedelic mushrooms.NeonMind and

2020-05-07 6:00 AM EDT

Yield Growth Announces Subsidiary Name Change to NeonMind Biosciences Inc.

Vancouver, British Columbia--(Newsfile Corp. - April 30, 2020) - The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) ("Yield Growth") announces it has changed the name of its majority owned subsidiary to NeonMind Biosciences Inc. from Flourish Mushroom Labs Inc., a company engaged in research and development of potentially therapeutic uses of psychedelic mushrooms and development of functional mushroom products.

2020-04-30 9:00 AM EDT

Ready to Announce with Confidence?

Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us